跳至主要内容
临床试验/DRKS00024032
DRKS00024032招募中未知

Feasibility study on the value of PET/MRI compared to PET/CT in oncological patients with a molecularly oriented individualized therapy concept - MTB_PET/fMRI (PET/MR_Tü-021)

niversitätsklinikum Tübingen0 个研究点目标入组 50 人开始时间: 2021年1月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Presence of a tumor disease and presentation of the patient in the Molecular Tumor Board (MTB) of the University Hospital Tübingen
  • Performing a PET/CT based on a clinical indication (MTB)
  • The patient tolerates about 60 minutes of lying in the tomograph
  • Age =18 years
  • Written consent from the patient

排除标准

  • Pregnant / breastfeeding women
  • Presence of non-MR compatible implants or any kind of metal in and on the body
  • Patients who report a hearing impairment or an increased sensitivity to loud noises
  • Patients with limited temperature sensation
  • Claustrophobia
  • Limited ability to give consent
  • Obesity with a body weight of> 150 kg
  • No consent to the communication of incidental findings

研究者

发起方
niversitätsklinikum Tübingen

相似试验